Brokers Suggest Investing in Accenture (ACN): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Accenture (ACN) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Accenture currently has an average brokerage recommendation (ABR) of 1.70, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 27 brokerage firms. An ABR of 1.70 approximates between Strong Buy and Buy.Of the 27 recommendations that derive the current ABR, 17 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 63% and 3.7% of all recommendations.Brokerage Recommendation Trends for ACNCheck price target & stock forecast for Accenture here>>>While the ABR calls for buying Accenture, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Is ACN Worth Investing In?Looking at the earnings estimate revisions for Accenture, the Zacks Consensus Estimate for the current year has increased 0% over the past month to $12.77.Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Accenture. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Accenture may serve as a useful guide for investors.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accenture PLC (ACN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Accenture
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Accenture
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Accenture plc
Analysen zu Accenture plc
Datum | Rating | Analyst | |
---|---|---|---|
20.09.2018 | Accenture Buy | Deutsche Bank AG | |
20.03.2018 | Accenture Outperform | Wedbush Morgan Securities Inc. | |
22.12.2017 | Accenture Buy | Pivotal Research Group | |
22.12.2017 | Accenture Equal Weight | Barclays Capital | |
22.12.2017 | Accenture Overweight | Cantor Fitzgerald |
Datum | Rating | Analyst | |
---|---|---|---|
20.09.2018 | Accenture Buy | Deutsche Bank AG | |
20.03.2018 | Accenture Outperform | Wedbush Morgan Securities Inc. | |
22.12.2017 | Accenture Buy | Pivotal Research Group | |
22.12.2017 | Accenture Overweight | Cantor Fitzgerald | |
08.11.2017 | Accenture Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
22.12.2017 | Accenture Equal Weight | Barclays Capital | |
27.09.2017 | Accenture Equal Weight | Barclays Capital | |
22.12.2016 | Accenture Equal Weight | Barclays Capital | |
30.09.2016 | Accenture Equal Weight | Barclays Capital | |
28.03.2016 | Accenture Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
19.12.2011 | Accenture sell | Société Générale Group S.A. (SG) | |
01.10.2010 | Accenture sell | Kaufman Bros., LP | |
26.08.2010 | Accenture sell | Kaufman Bros., LP | |
26.09.2006 | Update Accenture Ltd. : Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accenture plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen